1
|
Erul E, Guven DC, Ozbay Y, Altunbulak AY, Kahvecioglu A, Ercan F, Yesil MF, Ucdal MT, Cengiz M, Yazici G, Kuscu O, Suslu N, Gullu I, Onur MR, Aksoy S. Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinoma. Biomark Med 2023; 17:87-99. [PMID: 37042459 DOI: 10.2217/bmm-2022-0748] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/13/2023] Open
Abstract
Background: We aimed to evaluate the effect of sarcopenia on survival in head and neck squamous cell carcinoma patients treated with chemoradiotherapy. Materials & methods: Disease-free survival and overall survival were compared according to cervical computed tomography for radiotherapy in 123 sarcopenic and non-sarcopenic patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiotherapy with weekly cisplatin. Results: In multivariate analyses, pretreatment sarcopenia was associated with lower disease-free survival (hazard ratio: 2.60; 95% CI: 1.38-4.87; p = 0.003) and overall survival (hazard ratio: 2.86; 95% CI: 1.40-5.85; p = 0.004). Sarcopenic patients experienced more frequent radiotherapy-related toxicities and platinum-related side effects than non-sarcopenic patients. Conclusion: Sarcopenia could be a potential biomarker to predict prognosis and treatment toxicity in head and neck squamous cell carcinoma.
Collapse
Affiliation(s)
- Enes Erul
- Department of Internal Medicine, Hacettepe University, Ankara, 06230, Turkey
| | - Deniz C Guven
- Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, 06230, Turkey
| | - Yakup Ozbay
- Department of Radiology, Hacettepe University, Ankara, 06230, Turkey
| | | | - Alper Kahvecioglu
- Department of Radiation Oncology, Hacettepe University, Ankara, 06230, Turkey
| | - Fatih Ercan
- Department of Internal Medicine, Hacettepe University, Ankara, 06230, Turkey
| | - Muhammed F Yesil
- Department of Internal Medicine, Hacettepe University, Ankara, 06230, Turkey
| | - Mete T Ucdal
- Department of Internal Medicine, Hacettepe University, Ankara, 06230, Turkey
| | - Mustafa Cengiz
- Department of Radiation Oncology, Hacettepe University, Ankara, 06230, Turkey
| | - Gozde Yazici
- Department of Radiation Oncology, Hacettepe University, Ankara, 06230, Turkey
| | - Oguz Kuscu
- Department of Otorhinolaryngology & Head & Neck Surgery, Hacettepe University, Ankara, 06230, Turkey
| | - Nilda Suslu
- Department of Otorhinolaryngology & Head & Neck Surgery, Hacettepe University, Ankara, 06230, Turkey
| | - Ibrahim Gullu
- Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, 06230, Turkey
| | - Mehmet R Onur
- Department of Radiology, Hacettepe University, Ankara, 06230, Turkey
| | - Sercan Aksoy
- Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, 06230, Turkey
| |
Collapse
|